2018
DOI: 10.1007/s10948-018-4841-2
|View full text |Cite
|
Sign up to set email alerts
|

A Review on Iron Oxide Nanoparticles and Their Biomedical Applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
85
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 172 publications
(86 citation statements)
references
References 61 publications
0
85
0
1
Order By: Relevance
“…Although different iron oxides and also Fe 3 O 4 have been previously applied for diagnosis and in tumor therapy (Sangaiya and Jayaprakash, 2018), the biocompatibility of functionalized Fe 3 O 4 MNPs is competitive to Fe 3 O 4 nanoparticles. The enhanced cytotoxicity for HeLa cells has been previously reported for L-cysteine-conjugated ruthenium oxy-hydroxide (RuO x (OH) y ) in comparison to RuO x (OH) y (Ganguly et al, 2018).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Although different iron oxides and also Fe 3 O 4 have been previously applied for diagnosis and in tumor therapy (Sangaiya and Jayaprakash, 2018), the biocompatibility of functionalized Fe 3 O 4 MNPs is competitive to Fe 3 O 4 nanoparticles. The enhanced cytotoxicity for HeLa cells has been previously reported for L-cysteine-conjugated ruthenium oxy-hydroxide (RuO x (OH) y ) in comparison to RuO x (OH) y (Ganguly et al, 2018).…”
Section: Resultsmentioning
confidence: 99%
“…The iron oxide nanoparticles, i.e., ferrimagnetic maghemite (γ-Fe 2 O 3 ) with Fe 3+ vacancies and ferrimagnetic magnetite (Fe 3 O 4 ≡ FeO•Fe 2 O 3 ) with Fe 2+ and Fe 3+ vacancies, have already been applied in the field of medicine due to their biocompatibility, biodegradability, and possibility to tailor magnetic behavior (Sangaiya and Jayaprakash, 2018), where the change of nanoparticle size, morphology, agglomeration, magnetic, and electronic properties influences the biological effect (Liu et al, 2016). Although magnetic targeting iron nanoparticles serve as platforms for attaching drugs like, e.g., doxorubicin (DOX), they were also applied in a tumor therapy, which resulted in a hyperthermia and oxidative stress leading to tumor cell damage (Rangam et al, 2017; Petran et al, 2018; Sangaiya and Jayaprakash, 2018). Enhancement of antitumor effect was obtained by functionalization of nanoparticles by a conventional DOX drug (Liu et al, 2016; Rangam et al, 2017) and/or doping with rare metals (Petran et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Maghemite (gamma‐phase iron oxide, γ‐Fe 2 O 3 ), especially in a nanoparticle form, has attracted much attention as a soft ferrimagnetic (or superparamagnetic) material with large coercivity (~5‐80 mT) for magnetic recording device, catalysts, magnetic resonance imaging, cancer treatment, and other electronic, biomedical, and environmental applications . These maghemite nanoparticles are synthesized by physical (ball milling and oxidization, deposition, spraying, etc.)…”
Section: Introductionmentioning
confidence: 99%
“…Among them, magnetic nanoparticles, the first generation of nanomaterials approved for clinical use, are particularly used owing to their superparamagnetic properties, which have increased the possibilities for developing novel and efficient biomedical applications [ 52 , 53 , 54 ], such as targeted drug and gene delivery, magnetic resonance imaging, biosensors, cancer detection and treatment, diagnosis and magnetic field-assisted radiotherapy, and tissue engineering [ 55 ]. The common types of iron oxide nanoparticles, which belong to the ferrimagnetic class of magnetic nanomaterials, are magnetite (Fe 3 O 4 ), maghemite (γ-Fe 2 O 3 ), hematite (α-Fe 2 O 3 ), and mixed ferrites (MFe 2 O 4 , where M = Co, Mn, Ni or Zn) [ 52 , 53 , 56 , 57 ].…”
Section: Magnetite Nanoparticles—synthesis Properties and Functimentioning
confidence: 99%